Clinical Trial Update: Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study assesses Eleclazine in adults with normal and impaired renal function to inform dosing considerations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome

Drugs mentioned

• Eleclazine (Eleclazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Long QT Syndrome | Phase 1 | Status: COMPLETED